Efficacy and safety of belimumab in lupus nephritis patients with nephrotic syndrome: a single-centre observational retrospective study
Belimumab showed comparable effectiveness and safety in LN patients with NS, providing valuable evidence for its real-world clinical use.
Authors
- Tiekun Yan (ORCID: https://orcid.org/0000-0003-0798-9731)
- Zhenfeng Zheng (ORCID: https://orcid.org/0000-0001-5065-9039)
- Junya Jia (ORCID: https://orcid.org/0000-0002-4344-132X)
- Qiu‐hua Gu (ORCID: https://orcid.org/0000-0002-3389-5950)
- Xinxin Zhang (ORCID: https://orcid.org/0000-0002-0598-6425)
- Wei Li (ORCID: https://orcid.org/0000-0001-7864-455X)
- Xi Cheng (ORCID: https://orcid.org/0009-0006-2075-7985)
- Wenya Shang
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1093/ckj/sfaf137
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City